In fact, increased p53 protein levels were observed by immunohistochemistry not only in anaplastic and poorly differentiated thyroid cancer where p53 mutations are frequent but also in well-differentiated cancers, in the absence of any p53 mutation [28]. This evidence concerns the gene TP53 and cancer.